Clinical Trials Logo

Filter by:
NCT ID: NCT06155357 Not yet recruiting - Atrial Fibrillation Clinical Trials

A Study of a Lifestyle Program on Recurrent Atrial Fibrillation

Start date: September 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the impact of a comprehensive lifestyle intervention, including cardiac rehabilitation, prior to catheter ablation (a procedure to stop abnormal electrical signals in the heart), on Atrial Fibrillation (AF)-related symptoms.

NCT ID: NCT06155292 Recruiting - Primary Health Care Clinical Trials

Report Cards and Feedback for PCCE

RCF: PCCE
Start date: October 3, 2023
Phase: N/A
Study type: Interventional

As part of UCLA Health's commitment to developing an integrated health system built on a foundation of physician-led, team-based primary care, the Department of Medicine (DOM) implemented a performance-based incentive plan called the Primary Care Clinical Excellence (PCCE) Incentive Plan. The UCLA Health DOM Quality team is leading the implementation and evaluation of this incentive plan across the UCLA Health primary care network, with the primary goal to immediately produce improvements in the quality of primary care. In order to rigorously measure the most efficacious ways to frame and communicate information about the quality improvement (QI) program, the DOM Quality team has partnered with the UCLA Anderson School of Management. Understanding the factors that motivate physicians to deliver high quality primary care will provide pivotal insights into the successful implementation of performance based programs nationwide.

NCT ID: NCT06155240 Recruiting - Hypertension Clinical Trials

Yoga for a Healthy Heart

YHH
Start date: October 31, 2023
Phase: N/A
Study type: Interventional

The Yoga for a Healthy Heart study will address various barriers to both medication management and blood pressure regulation for African American patients with hypertension.

NCT ID: NCT06154980 Recruiting - Pain Clinical Trials

Randomized Controlled Comparison of Pre-op TLIP vs Intra-op TLIP

Start date: August 2024
Phase: N/A
Study type: Interventional

Single-center, randomized study will enroll 50 subjects who are scheduled for 1-3 level posterior laminectomy & fusion. Study participants who are eligible for the posterior lumbar laminectomy and fusion procedure will be scheduled and also consented as a part of the study. Participants will be stratified based on age and gender to ensure equal distribution.

NCT ID: NCT06154590 Not yet recruiting - Chronic Pain Clinical Trials

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

NASBP-B-09
Start date: July 2024
Phase:
Study type: Observational [Patient Registry]

At a median follow-up of 33 months, the combination of anastrozole and NOLVADEX (tamoxifen citrate) did not demonstrate any efficacy benefit when compared to NOLVADEX (tamoxifen citrate) therapy given alone in all patients as well as in the hormone receptor positive subpopulation. This treatment arm was discontinued from the trial. This study is now a combination therapy whereas the median duration of adjuvant treatment for safety evaluation is 59.8 months and 59.6 months for patients receiving anastrozole 1 mg and NOLVADEX (tamoxifen citrate) 20 mg, respectively.

NCT ID: NCT06154447 Recruiting - Cystic Fibrosis Clinical Trials

A Phase 1, First-in-human Study of VX-828

Start date: December 12, 2023
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 in healthy participants.

NCT ID: NCT06154304 Not yet recruiting - Bronchial Asthma Clinical Trials

BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma

Start date: December 11, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product, using bronchoprovocation (methacholine challenge testing) in adult patients with stable mild asthma.

NCT ID: NCT06154265 Enrolling by invitation - Clinical trials for Coronary Artery Disease

Intraoperative Echocardiography in Low-Risk CABG Surgery

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This goal of this study is to better understand when and where intraoperative transesophageal echocardiography (TEE) should (or should not) be used during coronary artery bypass graft (CABG) surgeries.

NCT ID: NCT06154252 Recruiting - Dermatomyositis Clinical Trials

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy

Start date: December 20, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy

NCT ID: NCT06154226 Recruiting - Acute Kidney Injury Clinical Trials

Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor

Start date: January 10, 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether perioperative intravenous administration of pantoprazole will improve kidney function parameters following cardiac surgery with cardiopulmonary bypass compared to famotidine and to determine whether perioperative intravenous administration of pantoprazole will decrease the incidence of postoperative Acte Kidney Injury (AKI) and major adverse kidney events (MAKE).